Search research articles
Contact Us
Filters
Showing results (331-340 of 395) with videos related to
Page
of 40
Sort By:
Nature Communications
|
January 5, 2021
Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
Carleen Klumpp-Thomas, Heather Kalish, Matthew Drew, et al.
Pathology, Research and Practice
|
November 23, 2023
Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis
Milena Shizue Tariki, Caroline Correia Ghensev Barberan, Jacqueline Aparecida Torres, et al.
Plos One
|
October 17, 2012
Plasma uric acid levels correlate with inflammation and disease severity in Malian children with Plasmodium falciparum malaria
Tatiana M Lopera-Mesa, Neida K Mita-Mendoza, Diana L van de Hoef, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
Carleen Klumpp-Thomas, Heather Kalish, Matthew Drew, et al.
Plos One
|
August 2, 2014
Identification of ALK gene alterations in urothelial carcinoma
Joaquim Bellmunt, Shamini Selvarajah, Scott Rodig, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 13, 2024
PAI-1 Regulates the Cytoskeleton and Intrinsic Stiffness of Vascular Smooth Muscle Cells
Hekmat B Khoukaz, Manisha Vadali, Alex Schoenherr, et al.
The New England Journal of Medicine
|
October 9, 2009
A randomized trial of doxycycline for Mansonella perstans infection
Yaya I Coulibaly, Benoit Dembele, Abdallah A Diallo, et al.
The Lancet. Oncology
|
April 3, 2025
First-line talazoparib plus enzalutamide versus placebo plus enzalutamide for metastatic castration-resistant prostate cancer: patient-reported outcomes from the randomised, double-blind, placebo-controlled, phase 3 TALAPRO-2 trial
Nobuaki Matsubara, Arun A Azad, Neeraj Agarwal, et al.
The Lancet. Oncology
|
April 3, 2025
First-line talazoparib plus enzalutamide versus placebo plus enzalutamide in men with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: patient-reported outcomes from the randomised, double-blind, placebo-controlled, phase 3 TALAPRO-2 trial
Andre P Fay, Karim Fizazi, Nobuaki Matsubara, et al.
The Journal of Infectious Diseases
|
March 2, 2013
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity
Tatiana M Lopera-Mesa, Saibou Doumbia, Serena Chiang, et al.
Page
of 40
Search research articles
Search
Showing results (331-340 of 395) with videos related to
Sort By:
Page
of 40
Nature Communications
|
January 5, 2021
Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
Carleen Klumpp-Thomas, Heather Kalish, Matthew Drew, et al.
Pathology, Research and Practice
|
November 23, 2023
Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis
Milena Shizue Tariki, Caroline Correia Ghensev Barberan, Jacqueline Aparecida Torres, et al.
Plos One
|
October 17, 2012
Plasma uric acid levels correlate with inflammation and disease severity in Malian children with Plasmodium falciparum malaria
Tatiana M Lopera-Mesa, Neida K Mita-Mendoza, Diana L van de Hoef, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
Standardization of enzyme-linked immunosorbent assays for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling
Carleen Klumpp-Thomas, Heather Kalish, Matthew Drew, et al.
Plos One
|
August 2, 2014
Identification of ALK gene alterations in urothelial carcinoma
Joaquim Bellmunt, Shamini Selvarajah, Scott Rodig, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 13, 2024
PAI-1 Regulates the Cytoskeleton and Intrinsic Stiffness of Vascular Smooth Muscle Cells
Hekmat B Khoukaz, Manisha Vadali, Alex Schoenherr, et al.
The New England Journal of Medicine
|
October 9, 2009
A randomized trial of doxycycline for Mansonella perstans infection
Yaya I Coulibaly, Benoit Dembele, Abdallah A Diallo, et al.
The Lancet. Oncology
|
April 3, 2025
First-line talazoparib plus enzalutamide versus placebo plus enzalutamide for metastatic castration-resistant prostate cancer: patient-reported outcomes from the randomised, double-blind, placebo-controlled, phase 3 TALAPRO-2 trial
Nobuaki Matsubara, Arun A Azad, Neeraj Agarwal, et al.
The Lancet. Oncology
|
April 3, 2025
First-line talazoparib plus enzalutamide versus placebo plus enzalutamide in men with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: patient-reported outcomes from the randomised, double-blind, placebo-controlled, phase 3 TALAPRO-2 trial
Andre P Fay, Karim Fizazi, Nobuaki Matsubara, et al.
The Journal of Infectious Diseases
|
March 2, 2013
Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity
Tatiana M Lopera-Mesa, Saibou Doumbia, Serena Chiang, et al.
Page
of 40